Related Experiment Video
Updated: Aug 6, 2025

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Published on: August 4, 2022
A dynamic clamping approach using in silico IK1 current for discrimination of chamber-specific hiPSC-derived
Claudia Altomare1,2,3, Chiara Bartolucci4, Luca Sala5,6
1Cardiovascular Theranostics, Istituto Cardiocentro Ticino, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Insights
Human induced pluripotent stem cells (hiPSC)-derived cardiomyocytes (CM) are a mixed population. This study developed an automated electrophysiological classification method using dynamic clamp and machine learning to improve their use in research.
Area of Science:
- Cardiovascular Research
- Stem Cell Biology
- Computational Biology
Background:
- Human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes (CM) represent a heterogeneous cell population, including ventricular, atrial, and nodal-like subtypes.
- This cellular heterogeneity complicates the reliable study of chamber-specific cardiac diseases and electrophysiological mechanisms.
- Previous methods for classifying CM phenotypes based on action potential morphology lacked defined criteria, limiting their utility.
Purpose of the Study:
- To develop an automated, in silico approach for discriminating electrophysiological differences among hiPSC-CM.
- To establish objective criteria for classifying hiPSC-CM phenotypes.
- To enhance the translational relevance of hiPSC-CM for studying cardiac arrhythmias and drug screening.
Main Methods:
- Utilized the dynamic clamp (DC) technique to inject a specific IK1 current into hiPSC-CM.
- Derived nine electrical biomarkers to characterize cell electrophysiology.
- Applied unsupervised learning algorithms and principal component analysis for blind CM phenotype classification and visualization.
- Conducted pharmacological validation using specific ion channel blockers and receptor agonists.
Main Results:
- Successfully discriminated electrophysiological differences between hiPSC-CM subtypes.
- Developed an automated classification system for hiPSC-CM phenotypes.
- Demonstrated the utility of the derived electrical biomarkers and classification approach.
- Pharmacological validation confirmed the robustness of the CM classification.
Conclusions:
- The proposed dynamic clamp-based approach with machine learning provides an automated and reliable method for classifying hiPSC-CM electrophysiologically.
- This method improves the translational relevance of hiPSC-CM models for investigating inherited or acquired atrial arrhythmias.
- The approach is valuable for screening anti-arrhythmic agents and advancing the study of human cardiac electrophysiology.
Abstract:
Human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes (CM) constitute a mixed population of ventricular-, atrial-, nodal-like cells, limiting the reliability for studying chamber-specific disease mechanisms. Previous studies characterised CM phenotype based on action potential (AP) morphology, but the classification criteria were still undefined. Our aim was to use in silico models to develop an automated approach for discriminating the electrophysiological differences between hiPSC-CM. We propose the dynamic clamp (DC) technique with the injection of a specific IK1 current as a tool for deriving nine electrical biomarkers and blindly classifying differentiated CM. An unsupervised learning algorithm was applied to discriminate CM phenotypes and principal component analysis was used to visualise cell clustering. Pharmacological validation was performed by specific ion channel blocker and receptor agonist. The proposed approach improves the translational relevance of the hiPSC-CM model for studying mechanisms underlying inherited or acquired atrial arrhythmias in human CM, and for screening anti-arrhythmic agents.
More Related Videos
08:03Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
Published on: October 20, 2022
14:03High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
Published on: March 24, 2023